Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112089
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112089
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112089
Table 1 General patient information
| Item | Category | Number of cases | Percentage |
| Basic characteristics | |||
| Sex | Male | 32 | 64% |
| Female | 18 | 36% | |
| Family history | Yes | 16 | 32% |
| Behavioral risk factors | Smoking | 5 | 10% |
| Alcohol consumption | 5 | 10% | |
| Tumor characteristics | |||
| Primary site | Stomach | 15 | 30% |
| Intestine | 35 | 70% | |
| Maximum tumor diameter | > 5 cm | 23 | 46% |
| ≤ 5 cm | 16 | 32% | |
| Infiltrative growth difficult to evaluate | 11 | 22% | |
| Clinical manifestations | |||
| Initial symptom | Abdominal pain | 26 | 52% |
| Abdominal mass | 8 | 16% | |
| Mass with pain | 2 | 4% | |
| Hematochezia or melena | 7 | 14% | |
| Others | 7 | 14% | |
| Concurrent symptoms | Pain | 40 | 80% |
| Hematochezia/melena | 19 | 38% | |
| Nausea and vomiting | 16 | 32% | |
| Weight loss | 18 | 36% | |
| Anemia | 19 | 38% | |
| Comorbidities | Cardiac disease | 8 | 16% |
| Chest disease | 20 | 40% | |
| Gastritis | 13 | 26% | |
| Liver disease | 17 | 34% | |
| Gallbladder disease | 8 | 16% | |
| Other abdominal diseases | 28 | 56% | |
| Central nervous system disease | 5 | 10% | |
| Hypertension | 10 | 20% | |
| Diabetes | 7 | 14% | |
| Metastasis to other sites | 30 | 60% | |
Table 2 Auxiliary examination results
| Characteristics | Number of examinations | Positive diagnoses | Percentage |
| Ultrasound | 49 | 18 | 36.7% |
| CT | 35 | 33 | 94.3% |
| PET-CT | 36 | 24 | 66.7% |
| Endoscopy | 47 | 43 | 91.5% |
Table 3 Staging and risk
| Characteristics | Classification | Number of cases | Percentage |
| Lugano stage | I | 10 | 20% |
| II | 22 | 44% | |
| III | 6 | 12% | |
| IV | 12 | 24% | |
| IPI risk | Low | 29 | 58% |
| Low-intermediate | 10 | 20% | |
| High-intermediate | 9 | 18% | |
| High | 2 | 4% |
Table 4 Treatment outcomes
| Characteristics | Classification | Number of cases | Percentage |
| Surgery group | Improvement | 9 | 40.9% |
| Stable | 5 | 22.7% | |
| Deterioration | 8 | 36.3% | |
| Non-surgery group | Improvement | 4 | 25.0% |
| Stable | 6 | 37.5% | |
| Deterioration | 6 | 37.5% |
- Citation: Yang CX, Xu LX, Liu J, Qiao HL, Dong ZW, Jiang D, Gu GL. Clinicopathological characteristics and surgical value of primary gastrointestinal lymphoma. World J Gastrointest Oncol 2025; 17(11): 112089
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/112089.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.112089
